Noninvasive preimplantation genetic testing for aneuploidy in spent blastocyst media will substitute for trophectoderm biopsy

Fertile Battle
Published
Go to the profile of Fertility and Sterility
Fertility and Sterility
Editorial Office, American Society for Reproductive Medicine
Noninvasive preimplantation genetic testing for aneuploidy in spent blastocyst media will substitute for trophectoderm biopsy
Like

Related Content

Fertility and Sterility
Fertility and Sterility Fertility and Sterility

Noninvasive preimplantation genetic testing for aneuploidy in spent blastocyst media will substitute for trophectoderm biopsy

The discovery of cell-free fetal deoxyribonucleic acid in maternal plasma has enabled a paradigm shift in prenatal testing (1). Since its inception, noninvasive prenatal testing (niPGT) has dramatically changed clinical practice in prenatal care, allowing safer and earlier detection of genetic condi…

VOLUME 115, ISSUE 4, P840

Author:

Carlos Simon, M.D., Ph.D.

Abstract:

The discovery of cell-free fetal deoxyribonucleic acid in maternal plasma has enabled a paradigm shift in prenatal testing (1). Since its inception, noninvasive prenatal testing (niPGT) has dramatically changed clinical practice in prenatal care, allowing safer and earlier detection of genetic conditions of the fetus during the first trimester of pregnancy (2).

Read the full text here. 

Go to the profile of Fertility and Sterility
Fertility and Sterility
Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. 

Recommended Content